1. Design, synthesis and biological evaluation of artesunate-Se derivatives as anticancer agents by inducing GPX4-mediated ferroptosis
   Meilin Ren et al, 2024, Bioorganic Chemistry CrossRef
2. Artemisinin pre-treatment fore cisplatin dosage enhances high grade urothelial carcinoma treatment in male albino mice via reverse gene expression modulation of FGFR3, HRAS, P53 and KDM6A
   Silvia Botrous et al, 2024, BMC Cancer CrossRef
3. Artesunate alleviates radiation‐induced submandibular gland epithelial cell damage in rats by reducing inflammation and apoptosis
   Yuchen Wang et al, 2024, Cell Biology International CrossRef
4. Anti-tumor mechanism of artesunate
   Xiaoyu Fan et al, 2024, Frontiers in Pharmacology CrossRef
5. Targeting ferroptosis as a potential strategy to overcome the resistance of cisplatin in oral squamous cell carcinoma
   Rongkun Chen et al, 2024, Frontiers in Pharmacology CrossRef
6. Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian Cancer
   J. Robert McCorkle et al, 2024, Cancers CrossRef
7. Elucidating the role of FOS in modulating the immune microenvironment through fibroblast and myeloid cell regulation in locoregional recurrent HNSCC
   Shaokun Liu et al, 2024, Environmental Toxicology CrossRef